Table 4.
Clinical and hemodynamic data of 15 patients who completed BPA treatment.
| Baseline | After BPA | Change (%) | p-Value | |
|---|---|---|---|---|
| mRAP (mmHg) | 10.0 ± 4.2 | 6.6 ± 2.9 | −34 | <0.001 |
| Systolic PAP (mmHg) | 76.8 ± 23.7 | 40.6 ± 11.9 | −47 | <0.001 |
| mean PAP (mmHg) | 47.8 ± 13.5 | 26.4 ± 7.6 | −45 | <0.001 |
| PVR (WU) | 10.0 ± 5.0 | 3.7 ± 2.8 | −63 | <0.001 |
| CI (L/min/m2) | 2.23 ± 0.7 | 2.51 ± 0.36 | +11 | 0.143 |
| HR | 84 ± 10 | 68 ± 12 | −19 | <0.001 |
| SAO2 | 90.4 ± 5.1 | 95.3 ± 4.0 | +5 | 0.001 |
| SVO2 | 63.4 ± 8.2 | 67.3 ± 7.1 | +6 | 0.028 |
| NTproBNP (pg/mL) (median) |
925 ± 1238 (307) |
231 ± 327 (81) |
−75 (−74) |
0.012 |
| WHO FC (mean) (median) |
3.0 ± 0.7 3 |
1.9 ± 0.7 2 |
−37 | <0.001 |
| WHO FC I/II/III/IV (%) | 0/20/53.3/26.7 | 26.7/53.3/20/0 | ||
| Home Oxygen Therapy (n, %) | 13 (86.7) | 5 (33.3) | 0.001 | |
| Specific PH Treatment (n, %) | 11 (73.3) | 7 (46.7) | 0.041 |
BPA: Balloon Pulmonary Angioplasty, mRAP: mean Right Atrial Pressure, PAP: Pulmonary Arterial Pressure, PVR: Pulmonary Vascular Resistance, CI: Cardiac Index, HR: Heart Rate, SAO2: Arterial Oxygen Saturation, SVO2: Mixed Venous Oxygen Saturation, NTproBNP: N-terminal pro Brain Natriuretic Peptide, WHO FC: World Health Organization Functional Class, PH: Pulmonary Hypertension.